Fidelis Capital Partners LLC Acquires Shares of 967 CME Group Inc. (NASDAQ:CME)

Fidelis Capital Partners LLC bought a new position in CME Group Inc. (NASDAQ:CME) in the 3rd quarter, Holdings Channel reports. The firm bought 967 shares of the financial services provider’s stock, valued at approximately $220,000.

A number of other large investors have also recently made changes to their positions in CME. Wealth Enhancement Advisory Services LLC grew its position in CME Group by 21.2% in the 2nd quarter. Wealth Enhancement Advisory Services LLC now owns 48,205 shares of the financial services provider’s stock valued at $9,477,000 after acquiring an additional 8,443 shares during the last quarter. Duality Advisers LP bought a new stake in CME Group during the 1st quarter valued at about $1,455,000. SG Americas Securities LLC boosted its position in CME Group by 312.2% in the 1st quarter. SG Americas Securities LLC now owns 56,768 shares of the financial services provider’s stock valued at $12,222,000 after buying an additional 42,996 shares during the period. Cetera Investment Advisers grew its stake in CME Group by 429.1% in the 1st quarter. Cetera Investment Advisers now owns 47,521 shares of the financial services provider’s stock worth $10,231,000 after acquiring an additional 38,540 shares in the last quarter. Finally, Brookstone Capital Management increased its position in shares of CME Group by 12.2% during the second quarter. Brookstone Capital Management now owns 30,555 shares of the financial services provider’s stock worth $6,156,000 after acquiring an additional 3,325 shares during the period. 87.75% of the stock is owned by hedge funds and other institutional investors.

Insider Activity

In related news, Director Bryan T. Durkin sold 7,593 shares of the business’s stock in a transaction on Friday, August 30th. The shares were sold at an average price of $214.59, for a total transaction of $1,629,381.87. Following the completion of the transaction, the director now directly owns 55,607 shares in the company, valued at $11,932,706.13. The trade was a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. In other CME Group news, Director Bryan T. Durkin sold 7,593 shares of the business’s stock in a transaction that occurred on Friday, August 30th. The stock was sold at an average price of $214.59, for a total value of $1,629,381.87. Following the completion of the transaction, the director now directly owns 55,607 shares of the company’s stock, valued at approximately $11,932,706.13. The trade was a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, CFO Lynne Fitzpatrick sold 754 shares of the firm’s stock in a transaction that occurred on Sunday, September 15th. The stock was sold at an average price of $216.99, for a total transaction of $163,610.46. Following the sale, the chief financial officer now directly owns 13,261 shares in the company, valued at $2,877,504.39. The trade was a 0.00 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold 15,221 shares of company stock valued at $3,351,895 in the last ninety days. Insiders own 0.30% of the company’s stock.

CME Group Stock Performance

Shares of CME Group stock opened at $225.36 on Friday. The company has a quick ratio of 1.02, a current ratio of 1.02 and a debt-to-equity ratio of 0.10. CME Group Inc. has a 52 week low of $190.70 and a 52 week high of $230.36. The firm has a market capitalization of $81.14 billion, a P/E ratio of 25.64, a PEG ratio of 7.76 and a beta of 0.55. The company has a 50 day moving average price of $220.36 and a 200 day moving average price of $209.34.

CME Group (NASDAQ:CME) last announced its quarterly earnings data on Wednesday, October 23rd. The financial services provider reported $2.68 earnings per share for the quarter, beating analysts’ consensus estimates of $2.65 by $0.03. The business had revenue of $1.58 billion for the quarter, compared to analyst estimates of $1.59 billion. CME Group had a return on equity of 12.82% and a net margin of 56.98%. The company’s revenue was up 18.4% on a year-over-year basis. During the same period in the prior year, the company earned $2.25 earnings per share. Sell-side analysts expect that CME Group Inc. will post 10.04 EPS for the current year.

CME Group Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Wednesday, September 25th. Stockholders of record on Monday, September 9th were issued a $1.15 dividend. This represents a $4.60 annualized dividend and a dividend yield of 2.04%. The ex-dividend date of this dividend was Monday, September 9th. CME Group’s dividend payout ratio (DPR) is currently 52.33%.

Analysts Set New Price Targets

A number of analysts recently issued reports on the company. Citigroup boosted their price target on CME Group from $250.00 to $255.00 and gave the company a “buy” rating in a report on Thursday, October 24th. Morgan Stanley upped their target price on CME Group from $210.00 to $233.00 and gave the stock an “equal weight” rating in a report on Thursday, October 17th. Oppenheimer raised their price target on CME Group from $245.00 to $258.00 and gave the company an “outperform” rating in a research note on Thursday, October 24th. Keefe, Bruyette & Woods upped their price objective on shares of CME Group from $212.00 to $213.00 and gave the stock a “market perform” rating in a research note on Thursday, July 25th. Finally, Deutsche Bank Aktiengesellschaft raised their target price on shares of CME Group from $193.00 to $200.00 and gave the company a “hold” rating in a research report on Thursday, August 15th. Four investment analysts have rated the stock with a sell rating, seven have assigned a hold rating and four have given a buy rating to the stock. According to data from MarketBeat.com, the company currently has a consensus rating of “Hold” and a consensus target price of $222.73.

CME Group Company Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.